Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
11.38
+0.65 (6.06%)
At close: Mar 6, 2026, 4:00 PM EST
11.36
-0.02 (-0.18%)
After-hours: Mar 6, 2026, 7:37 PM EST
Ekso Bionics Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 12.8 | 17.93 | 18.28 | 12.91 | 11.25 | |
| Revenue Growth (YoY) | -28.60% | -1.94% | 41.57% | 14.81% | 26.62% | |
| Cost of Revenue | 5.95 | 8.41 | 9.2 | 6.7 | 4.5 | |
| Gross Profit | 6.85 | 9.51 | 9.08 | 6.21 | 6.75 | |
| Selling, General & Admin | 17 | 16.69 | 19.71 | 18.75 | 18.56 | |
| Research & Development | 2.42 | 3.29 | 4.48 | 3.02 | 2.02 | |
| Operating Expenses | 19.42 | 19.97 | 24.19 | 21.77 | 20.58 | |
| Operating Income | -12.58 | -10.46 | -15.11 | -15.56 | -13.83 | |
| Interest Expense | -0.31 | -0.27 | -0.3 | -0.16 | -0.11 | |
| Currency Exchange Gain (Loss) | 1.94 | -0.97 | 0.35 | -0.69 | -0.88 | |
| Other Non Operating Income (Expenses) | 0 | 0.47 | -0.13 | 1.32 | 3.96 | |
| EBT Excluding Unusual Items | -10.95 | -11.22 | -15.2 | -15.08 | -10.86 | |
| Asset Writedown | -0.75 | - | - | - | - | |
| Other Unusual Items | - | -0.11 | - | - | 1.1 | |
| Pretax Income | -11.7 | -11.33 | -15.2 | -15.08 | -9.76 | |
| Net Income | -11.7 | -11.33 | -15.2 | -15.08 | -9.76 | |
| Preferred Dividends & Other Adjustments | 0.23 | - | - | - | - | |
| Net Income to Common | -11.92 | -11.33 | -15.2 | -15.08 | -9.76 | |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 1 | |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 1 | |
| Shares Change (YoY) | 80.51% | 45.38% | 6.98% | 5.65% | 71.26% | |
| EPS (Basic) | -4.91 | -8.43 | -16.44 | -17.45 | -12.01 | |
| EPS (Diluted) | -4.91 | -8.43 | -16.50 | -17.45 | -13.20 | |
| Free Cash Flow | -11.99 | -9.88 | -12.21 | -14.88 | -11.22 | |
| Free Cash Flow Per Share | -4.94 | -7.35 | -13.21 | -17.22 | -13.71 | |
| Gross Margin | 53.48% | 53.06% | 49.67% | 48.13% | 60.01% | |
| Operating Margin | -98.26% | -58.35% | -82.67% | -120.48% | -122.96% | |
| Profit Margin | -93.14% | -63.21% | -83.14% | -116.79% | -86.82% | |
| Free Cash Flow Margin | -93.67% | -55.13% | -66.80% | -115.26% | -99.72% | |
| EBITDA | -11 | -8.85 | -13.41 | -14.67 | -12.81 | |
| EBITDA Margin | -85.97% | -49.38% | -73.39% | -113.61% | -113.86% | |
| D&A For EBITDA | 1.57 | 1.61 | 1.7 | 0.89 | 1.02 | |
| EBIT | -12.58 | -10.46 | -15.11 | -15.56 | -13.83 | |
| EBIT Margin | -98.26% | -58.35% | -82.67% | -120.48% | -122.96% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.